Trial Information

Summary: Back Pain

The primary objective of this study is to demonstrate the short-term multiple-dose analgesic efficacy and safety of HKT-500 in subjects with low back pain. The secondary objective of this study is to assess the onset of analgesic effect of the HKT-500 in subjects with low back pain.

• Male/Female 18 years of age and older
• The subject has low back pain, classified as class 1 on the Quebec Task Force system on the Spinal Disorders, of duration of at least 2 weeks but less than 2 months at dosing (baseline). The subject needs to have a history of and /or currently having low back pain improvement with NSAIDs/acetaminophen.

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:55 AM